Literature DB >> 23645419

Unnecessary tests and procedures in patients presenting with solid tumors of the pancreas.

Michol Cooper1, Naeem A Newman, Andrew M Ibrahim, Edwin Lam, Joseph M Herman, Vikesh K Singh, Christopher L Wolfgang, Timothy M Pawlik, John L Cameron, Martin A Makary.   

Abstract

BACKGROUND: A computed tomography (CT) scan is often the only study needed prior to surgery for resectable solid pancreas masses. However, many patients are evaluated with multiple studies and interventions that may be unnecessary.
METHODS: We conducted a retrospective review of patients who presented to the Johns Hopkins Multidisciplinary Pancreas Cancer Clinic with a clearly resectable solid pancreas mass, >1 cm in size over a 2-year period (6/2007-6/2009) and underwent resection. Pancreas specialists reviewed patient records and identified an index CT with a solid pancreas mass deemed to be resectable for curative intent. Data were collected on all studies and interventions between the index CT and the surgery.
RESULTS: A total of 101 patients had an index CT. Following the index CT and before surgery, 78 patients had at least one CT, 19 had magnetic resonance imaging, 9 had a positron emission tomography scan, and 66 underwent pancreatic biopsy. Patients underwent a mean of three studies with a mean added cost of $3,371 per patient. Preoperative tests and interventions were associated with a longer time to definitive surgical intervention.
CONCLUSION: Wide variation exists for evaluation of newly discovered resectable solid pancreas masses, which is associated with delays to surgical intervention and added costs.

Entities:  

Mesh:

Year:  2013        PMID: 23645419      PMCID: PMC4048022          DOI: 10.1007/s11605-013-2213-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  24 in total

1.  Estimating health care costs related to cancer treatment from SEER-Medicare data.

Authors:  Martin L Brown; Gerald F Riley; Nicki Schussler; Ruth Etzioni
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

Review 2.  Preoperative imaging of pancreatic cancer: a management-oriented approach.

Authors:  Damian L Clarke; Sandie R Thomson; Thandinkosi E Madiba; Charles Sanyika
Journal:  J Am Coll Surg       Date:  2003-01       Impact factor: 6.113

3.  Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Authors:  Douglas B Evans; Michael B Farnell; Keith D Lillemoe; Charles Vollmer; Steven M Strasberg; Richard D Schulick
Journal:  Ann Surg Oncol       Date:  2009-04-23       Impact factor: 5.344

4.  No surgical innovation without evaluation: the IDEAL recommendations.

Authors:  Peter McCulloch; Douglas G Altman; W Bruce Campbell; David R Flum; Paul Glasziou; John C Marshall; Jon Nicholl; Jeffrey K Aronson; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; Liane S Feldman; David R Flum; Guy J Maddern; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Steven M Strasberg; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Patrick L Ergina; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Jonathan Meakins; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

5.  Evaluation and stages of surgical innovations.

Authors:  Jeffrey S Barkun; Jeffrey K Aronson; Liane S Feldman; Guy J Maddern; Steven M Strasberg; Douglas G Altman; Jeffrey S Barkun; Jane M Blazeby; Isabell C Boutron; W Bruce Campbell; Pierre-Alain Clavien; Jonathan A Cook; Patrick L Ergina; David R Flum; Paul Glasziou; John C Marshall; Peter McCulloch; Jon Nicholl; Bournaby C Reeves; Christoph M Seiler; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

Review 6.  Evidence-based imaging of pancreatic malignancies.

Authors:  Timothy Kinney
Journal:  Surg Clin North Am       Date:  2010-04       Impact factor: 2.741

Review 7.  Pancreatic cancer.

Authors:  Audrey Vincent; Joseph Herman; Rich Schulick; Ralph H Hruban; Michael Goggins
Journal:  Lancet       Date:  2011-05-26       Impact factor: 79.321

8.  Challenges in evaluating surgical innovation.

Authors:  Patrick L Ergina; Jonathan A Cook; Jane M Blazeby; Isabelle Boutron; Pierre-Alain Clavien; Barnaby C Reeves; Christoph M Seiler; Douglas G Altman; Jeffrey K Aronson; Jeffrey S Barkun; W Bruce Campbell; Jonathan A Cook; Liane S Feldman; David R Flum; Paul Glasziou; Guy J Maddern; John C Marshall; Peter McCulloch; Jon Nicholl; Steven M Strasberg; Jonathan L Meakins; Deborah Ashby; Nick Black; John Bunker; Martin Burton; Marion Campbell; Kalipso Chalkidou; Iain Chalmers; Marc de Leval; Jon Deeks; Adrian Grant; Muir Gray; Roger Greenhalgh; Milos Jenicek; Sean Kehoe; Richard Lilford; Peter Littlejohns; Yoon Loke; Rajan Madhock; Kim McPherson; Peter Rothwell; Bill Summerskill; David Taggart; Parris Tekkis; Matthew Thompson; Tom Treasure; Ulrich Trohler; Jan Vandenbroucke
Journal:  Lancet       Date:  2009-09-26       Impact factor: 79.321

Review 9.  Preoperative evaluation of pancreatic adenocarcinoma.

Authors:  Colin M Parsons; Julie L Sutcliffe; Richard J Bold
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-08-01

10.  Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: Performance and outcomes.

Authors:  Leon Fisher; Dev Shankar Segarajasingam; Colin Stewart; W Bastiaan Deboer; Ian Fuad Yusoff
Journal:  J Gastroenterol Hepatol       Date:  2009-01       Impact factor: 4.029

View more
  6 in total

Review 1.  Overuse of Health Care Services in the Management of Cancer: A Systematic Review.

Authors:  Shrujal S Baxi; Minal Kale; Salomeh Keyhani; Benjamin R Roman; Annie Yang; Antonio P Derosa; Deborah Korenstein
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

2.  Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argument.

Authors:  Jeffrey M Sutton; Gregory C Wilson; Ian M Paquette; Koffi Wima; Dennis J Hanseman; R Cutler Quillin; Jeffrey J Sussman; Michael J Edwards; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  HPB (Oxford)       Date:  2014-07-16       Impact factor: 3.647

3.  Utilization of preoperative endoscopic ultrasound for pancreatic adenocarcinoma.

Authors:  Ryan K Schmocker; David J Vanness; Caprice C Greenberg; Jeff A Havlena; Noelle K LoConte; Jennifer M Weiss; Heather B Neuman; Glen Leverson; Maureen A Smith; Emily R Winslow
Journal:  HPB (Oxford)       Date:  2017-02-23       Impact factor: 3.647

4.  Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis.

Authors:  Amar B Deshwar; Elizabeth Sugar; Deirdre Torto; Ana De Jesus-Acosta; Matthew J Weiss; Christopher L Wolfgang; Dung Le; Jin He; Richard Burkhart; Lei Zheng; Daniel Laheru; Mark Yarchoan
Journal:  Ann Pancreat Cancer       Date:  2018-02-27

5.  Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.

Authors:  J S Ankeny; C M Court; S Hou; Q Li; M Song; D Wu; J F Chen; T Lee; M Lin; S Sho; M M Rochefort; M D Girgis; J Yao; Z A Wainberg; V R Muthusamy; R R Watson; T R Donahue; O J Hines; H A Reber; T G Graeber; H R Tseng; J S Tomlinson
Journal:  Br J Cancer       Date:  2016-06-14       Impact factor: 7.640

6.  Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer.

Authors:  R Pandé; J Hodson; A Murray; F Marcon; M Kalisvaart; R Marudanayagam; R P Sutcliffe; D F Mirza; J Isaac; K J Roberts
Journal:  BJS Open       Date:  2019-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.